New parameters for identifying subclinical atherosclerosis in patients with primary Sjögren's syndrome: A pilot study

Clinical and Experimental Rheumatology

Volumn 32, Issue 3, 2014, Pages 361-368

  Atzeni, Fabiola ^a   Sarzi puttini, Piercarlo ^a   Signorello, Maria Chiara ^b   Gianturco, Luigi ^b   Stella, Daniele ^b   Boccassini, Laura ^a   Ricci, Cristian ^c   Bodini, Bruno Dino ^b   Batticciotto, Alberto ^a   De Gennaro Colonna, Vito ^d   Drago, Lorenzo ^b,e   Turiel, Maurizio ^b  

^a UNIVERSITY OF MILAN   (Italy)

^b IRCCS ISTITUTO ORTOPEDICO GALEAZZI   (Italy)

^c UNIVERSITY OF REGENSBURG   (Germany)

^d UNIVERSITY OF MILAN   (Italy)

^e UNIVERSITY OF MILAN   (Italy)

Author keywords

Arterial stiffness; Atherosclerosis; Connective tissue diseases; Sj gren's syndrome; Speckle tracking echocardiography

Indexed keywords

N(G),N(G) DIMETHYLARGININE;

ADULT; AMINO ACID BLOOD LEVEL; ARTERIAL STIFFNESS; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROSIS; BODY MASS; CLINICAL ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; CORONARY FLOW RESERVE; ENDOTHELIAL DYSFUNCTION; FEMALE; HEART RATE; HEART VENTRICLE WALL MOTION; HUMAN; MALE; MYOCARDIAL DISEASE; PILOT STUDY; PRIORITY JOURNAL; PULSE WAVE; SJOEGREN SYNDROME; SUBCLINICAL ATHEROSCLEROSIS; TRANSTHORACIC ECHOCARDIOGRAPHY;

AGED; ARGININE; ATHEROSCLEROSIS; CAROTID INTIMA-MEDIA THICKNESS; CORONARY CIRCULATION; ECHOCARDIOGRAPHY; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; MALE; MIDDLE AGED; PILOT PROJECTS; PULSE WAVE ANALYSIS; RISK FACTORS; SJOGREN'S SYNDROME; VASCULAR STIFFNESS;

EID: 84901832875     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. RAMOS-CASALS M, TZIOUFAS AG, FONT J: Primary Sjögren's syndrome: new clinical and therapeutic concepts. Ann Rheum Dis 2005; 64: 347-54.
2. BAYETTO K, LOGAN RM: Sjögren's syndrome:a review of aetiology, pathogenesis, diagnosis and management. Aust Dent J 2010; 55 (Suppl. 1): 39-47.
3. AGMON-LEVIN N, LIAN Z, SHOENFELD Y: Explosion of autoimmune diseases and the mosaic of old and novel factors. Cell Mol Immunol 2011; 8: 189-92.
4. SCHEIN OD, HOCHBERG MC, MUÑOZ B et al.: Dry eye and dry mouth in the elderly: a population-based assessment. Arch Intern Med. 1999; 159: 1359-63.
5. RAUTAHARJU PM, KOOPERBERG C, LARSON JC et al.: Electrocardiographic abnormalities that predict coronary heart disease events and mortality in postmenopausal women: the Women's Health Initiative. Circulation 2006; 113: 473-80.
6. CORRADO E, RIZZO M, MURATORI I et al.: Older age and markers of inflammation are strong predictors of clinical events in women with asymptomatic carotid lesions. Menopause 2008; 15: 240-7.
7. LODDE BM, SANKAR V, KOK MR et al.: Serum lipid levels in Sjögren's syndrome. Rheumatology (Oxford) 2006; 45: 481-4.
8. VAUDO G, BOCCI EB, SHOENFELD Y et al.: Precocious intima-media thickening in patients with primary Sjögren's syndrome. Arthritis Rheum 2005; 52: 3890-7.
9. GERLI R, VAUDO G, BOCCI EB et al.: Functional impairment of the arterial wall in primary Sjögren's syndrome: combined action of immunologic and inflammatory factors. Arthritis Care Res (Hoboken) 2010; 62: 712-8.
10. TURIEL M, ATZENI F, TOMASONI L et al.: Non-invasive assessment of coronary flow reserve and ADMA levels: a case-control study of early rheumatoid arthritis patients. Rheumatology (Oxford) 2009; 48: 834-9.
11. KEREKES G, SOLTÉSZ P, NURMOHAMED MT et al.: Validated methods for assessment of subclinical atherosclerosis in rheumatology. Nat Rev Rheumatol 2012; 8: 224-34.
12. De GENNARO COLONNA V, BIANCHI M et al.: Asymmetric dimethylarginine (ADMA): an endogenous inhibitor of nitric oxide synthase and a novel cardiovascular risk mole-cule. Med Sci Monit 2009; 15: 91-101.
13. BRUZZESE V, MARRESE C, ZULLO A et al.: Carotid artery intima-media thickness in patients with autoimmune connective tissue diseases: a case-control study. Intern Emerg Med 2013; 8: 713-6.
14. SOLTÉSZ P, KEREKES G, DÉR H et al.: Comparative assessment of vascular function in autoimmune rheumatic diseases: considerations of prevention and treatment. Autoimmun Rev 2011; 10: 416-25.
15. TURIEL M, GIANTURCO L, RICCI C et al.: Silent cardiovascular involvement in patients with diffuse scleroderma: A controlled cross-sectional study. Arthritis Care Res (Hoboken) 2013; 65: 274-80.
16. ATZENI F, SARZI-PUTTINI P, De BLASIO G et al.: Preclinical impairment of coronary flow reserve in patients with rheumatoid arthritis. Ann N Y Acad Sci 2007; 1108: 392-7.
17. SITIA S, TOMASONI L, CICALA S et al.: Detection of preclinical impairment of myocardial function in rheumatoid arthritis patients with short disease duration by speckle tracking echocardiography. Int J Cardiol 2012; 160: 8-14.
18. SHIBOSKI SC, SHIBOSKI CH, CRISWELL L et al.; Sjögren'sS InternatiIonal CollaboratiIve Clinical Aalliance (SICCA) research groups: American College of Rheumatology classification criteria for Sjögren's syndrome: a data-driven, expert consensus approach in the Sjögren's International Collaborative Clinical Alliance cohort. Arthritis Care Res (Hoboken) 2012; 64: 475-87.
19. GABIR MM, HANSON RL, DABELEA D et al.: The 1997 American Diabetes Association and 1999 World Health Organization criteria for hyperglycemia in the diagnosis and prediction. Diabetes Care 2000; 23: 1108-12.
20. CHOBANIAN AV, BAKRIS GL, BLACK HR et al.: National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 Report. JAMA 2003; 289: 2560-71.
21. SAHN DJ, DE MARIA A, KISSLO J et al.: The Committee on M-mode standardization of the American Society of Echocardiography. Recommendations regarding quantitation in M-mode echocardiography: Results of a survey of echocardiographic measurements. Circulation 1978; 58: 1072-113.
22. SCHILLER NB, SHAH PM, CRAWFORD M et al.: Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. J Am Soc Echocardiogr 1989 2: 358-67.
23. DEVEREUX RB, REICHEK N: Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation 1977; 55: 613-8.
24. QIUNONES MA, OTTO CM, STODDARD M et al.: Doppler quantification task force of the nomenclature and standards committee of the American Society of Echocardiography. Recommendations for quantification of Doppler Echocardiography. J Am Soc Echocardiogr 2002; 15: 167-84.
25. BLAND JM, ALTMAN DJ: Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986; 1: 307-10.
26. TOUBOUL PJ, HENNERICI MG, MEAIRS S et al.: (Advisory Board of the 3rd Watching the Risk Symposium 2004, 13th European Stroke Conference). Mannheim intima-media thickness consensus. Cerebrovasc Dis 2004; 18: 346-9.
27. SIDHU PS, ALLEN PL: Ultrasound assessment of internal carotid artery stenosis. Clin Radiol 1997; 52: 654-8.
28. ZWIEBEL WJ, KNIGHTON R: Protocol for color-duplex examination of the carotid arteries and Doppler evaluation of carotid stenoses. In: ZWIEBEL WJ (Ed.) Introduction to Vascular Ultrasonography, 3rd ed. Philadelphia:WB Saunders, 1992; 95-104.
29. HARADA A, OKADA T, NIKI K et al.: On-line non-invasive one-point measurements of pulse wave velocity. Heart Vessels 2002; 17: 61-8.
30. FRIEDEWALD WT, LEVI RI, FREDRICKSON DS: Estimation of the concentration of low density lipoprotein cholesterol in plasma without use of the ultracentrifuge. Clin Chem 1972; 18: 499-502.
31. Miyazaki H, MatsSuoka Cooke JP, et al.: Endogenous nitric oxide synthase inhibitor:a novel marker of atherosclerosis. Circulation 1999; 99: 1141-6.
32. SATTAR N, MC CAREY DW, CAPELL H, McCINNES IB: Explaining how "high-grade" systemic inflammation accelerates vascular risk in rheumatoid arthritis. Circulation 2003; 10: 2957-63.
33. AROSIO E, DE MARCHI S, RIGONI A, PRIOR M, DELVA P, LECHI A: Forearm hemodynamics, arterial stiffness and microcirculatory reactivity in RA. J Hypertens 2007; 25: 1273-8.
34. TEERLINK T: Determination of the endogenous nitric oxide synthase inhibitor asymmetric dimethylarginine in biological samples by HPLC. Methods Mol Med 2005; 108: 263-74.
35. SHEARN MA: Sjögren's syndrome: major problems in internal medicine II. Philadelphia, London, Toronto: W B Saunders Company, 1971; pp 143-5.
36. KANG EH, LEE YJ, HYON JY, YUN PY, SONG YW: Salivary cytokine profiles in primary Sjögren's syndrome differ from those in non-Sjögren sicca in terms of TNF-a levels and Th-1/Th-2 ratios. Clin Exp Rheumatol 2011; 29: 970-6.
37. CHIN CW, TAN RS, THUMBOO J: Endothelial function and arterial stiffness assessment as early surrogate markers of vascular risk in patients with systemic lupus erythematosus. Clin Exp Rheumatol 2013; 31: 295-301.
38. GHIADONI L, MOSCA M, TANI C, VIRDIS A, TADDEI S, BOMBARDIERI S: Clinical and methodological aspects of endothelial function in patients with systemic autoimmune diseases. Clin Exp Rheumatol 2008; 26: 680-7.
39. VOULGARELIS M, TZIOUFAS AG, MOUTSOPOULOS HM: Mortality in Sjögren's syndrome. Clin Exp Rheumatol 2008; 26 (Suppl. 51): S66-71.
40. MEYER O, HAÏM T, DRYLL A, LANSAMAN J, RYCKEWAERT A: Vascular endothelial cell injury in progressive systemic sclerosis and other connective tissue diseases. Clin Exp Rheumatol 1983; 1: 29-34.
41. CORTIGIANI L, RIGO F, GHERARDI S et al.: Implication of the continuous prognostic spectrum of Doppler echocardiographic derived coronary flow reserve on left anterior descending artery. Am J Cardiol 2010; 105: 158-62.
42. ATZENI F, SARZI-PUTTINI P, SITIA S et al.: Coronary flow reserve and asymmetric dimethylarginine levels: new measurements for identifying subclinical atherosclerosis in patients with psoriatic arthritis. J Rheumatol 2011; 38: 1661-4.
43. PÉREZ-De-LIS M, AKASBI M, SISÓ A et al.: Cardiovascular risk factors in primary Sjögren's syndrome: a case-control study in 624 patients. Lupus 2010; 19: 941-8.
44. RHO YH, OESER A, CHUNG CP et al.: Drugs to treat systemic lupus erythematosus: relationship between current use and cardiovascular risk factors. Arch Drug Inf 2008; 1: 23-8.
45. GYÖNGYÖSI M, POKORNY G, JAMBRIK Z et al.: Cardiac manifestations in primary Sjögren's syndrome. Ann Rheum Dis 1996; 55: 450-4.
46. DeMARIA A N, WISENBAUGH T W, SMITH M D et al.: Doppler echocardiographic evaluation of diastolic dysfunction. Circulation 1991; 84 (Suppl. I): I288-95.
47. GONZALEZ-JUANATEY C, TESTA A, GARCIA-CASTELO A et al.: Echocardiographic and Doppler findings in long-term treated rheumatoid arthritis patients without clinically evident cardiovascular disease. Semin Arthritis Rheum 2004; 33: 231-8.